Synergy Chc Corp Stock Price, News & Analysis

Synergy CHC Corp (NASDAQ: SNYR) will release third quarter 2025 financial results for the period ended September 30, 2025 on Thursday, November 13, 2025 before market open.

The company will host a conference call on the same day at 9:00 a.m. ET / 6:00 a.m. PT with CEO Jack Ross and CFO Jaime Fickett. A live webcast and a limited-time replay will be available on Synergy's Investor Relations website. Phone participants must register to receive dial-in details and are encouraged to join 15 minutes early to avoid delays.

Synergy CHC Corp. (NASDAQ: SNYR) announced on October 27, 2025 that its brain-health brand FOCUSfactor was named the #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026 in the Pharmacy Times annual pharmacist survey.

The survey ranks brands most often recommended by U.S. pharmacists across OTC categories. FOCUSfactor was cited as the top Memory Support brand, reflecting over 20 years of category leadership and the company’s focus on clinically-studied cognitive formulations and multi-channel distribution.

Synergy CHC (NASDAQ: SNYR) announced expanded retail authorizations and distribution for FOCUSfactor supplements and FOCUSfactor Focus + Energy beverages across the U.S., Canada, and international markets.

Key placements include Kroger: three supplement SKUs in 1,600 stores beginning April 2026; Wakefern: five beverage SKUs in 365 stores; Uniprix: supplement SKUs in 300 Canadian stores beginning February 2026; and PriceSmart: a 12-pack beverage launch in 47 clubs across 13 countries, reaching >3 million members. Additional U.S. and Canadian retail rollouts were also disclosed.

Synergy CHC Corp. (NASDAQ: SNYR) announced a strategic distribution partnership with Atlantic Importing Company on Oct 20, 2025 to expand FOCUSfactor® Focus + Energy beverages across Massachusetts, Connecticut, and Rhode Island. The agreement uses Atlantic Importing’s regional retail network to accelerate availability in convenience stores, grocery chains, and independent retailers, supporting Synergy’s national beverage rollout and planned late-2025 product launches. The collaboration emphasizes clinically studied, nootropic-infused formulations positioned for the fast-growing functional beverage and brain-health market.

Synergy CHC Corp. (NASDAQ: SNYR) announced two significant leadership changes to strengthen its position in the functional beverages market. Scott Woodburn, a former Coca-Cola VP and current board member, has been appointed as Head of Strategic Partnerships to lead the company's FOCUSfactor Energy Drink expansion. Woodburn brings over 30 years of executive leadership in the beverage industry.

Additionally, Teresa Thompson, a veteran Costco executive with nearly 40 years of retail experience, has been appointed to Synergy's Board of Directors. Thompson, who spent 29 years as Costco's Pharmacy OTC Buyer, will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees.

The appointments align with Synergy's strategic expansion into the $100B+ global energy and wellness drinks market through its FOCUSfactor Energy Drinks line, which features B-vitamins and nootropics for mental clarity and clean energy.

Synergy CHC Corp. (NASDAQ: SNYR) has announced a strategic distribution partnership with AlaBev to launch its FOCUSfactor® Focus + Energy functional beverage line across Alabama. The partnership will enable distribution to over 5,000 retail outlets including grocery, convenience, and specialty stores.

AlaBev, with 120 years of experience and three warehouses, will leverage its direct-store-delivery network to expand FOCUSfactor's presence in one of the fastest-growing wellness and functional beverage markets. The partnership represents a significant milestone in Synergy's Southeast expansion strategy, targeting consumers seeking cognitive performance and brain health products.

Synergy CHC Corp. (Nasdaq: SNYR), a consumer health and wellness company, has successfully closed its underwritten public offering of 1,750,000 shares of common stock at $2.50 per share, raising gross proceeds of $4.375 million.

The company granted underwriters a 45-day option to purchase up to 262,500 additional shares and issued warrants to purchase up to 52,500 shares (or 60,375 if over-allotment is exercised). The warrants will expire in tranches over 3-5 years, with exercise eligibility beginning 180 days from closing.

Bancroft Capital, LLC served as the sole book-running manager for this offering, which was conducted under an SEC-registered Form S-1 declaration.

Synergy CHC Corp (NASDAQ:SNYR) has announced the pricing of an underwritten public offering of 1.75 million shares of common stock at $2.50 per share, aiming to raise $4.375 million in gross proceeds.

The offering includes a 45-day option for underwriters to purchase up to 262,500 additional shares. The Company will also issue underwriter warrants for up to 52,500 shares (or 60,375 if over-allotment is exercised), exercisable after 180 days. The warrants will expire in tranches over 3-5 years. The offering is expected to close on August 27, 2025, with proceeds intended for working capital and general corporate purposes.

Synergy CHC Corp (NASDAQ: SNYR), a consumer health and wellness company, will present at the 2025 Annual Gateway Conference in San Francisco. The presentation is scheduled for September 4th at 9:30 a.m. PT at the Four Seasons Hotel.

The event will feature a live webcast with replay availability, and company executives will be available for one-on-one meetings throughout the conference. Interested parties can request invitations or schedule meetings via email at conference@gateway-grp.com.